ID

24609

Descrizione

PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00508586

collegamento

https://clinicaltrials.gov/show/NCT00508586

Keywords

versioni (1)
  1. 08/08/17 08/08/17 -
Caricato su

8 agosto 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Metastatic Breast Cancer NCT00508586

Inglese

Eligibility Metastatic Breast Cancer NCT00508586

1 moduli  
Criteria
Descrizione

Criteria

1. female sex.
Descrizione

Gender

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0079399
2. age ≥18 years.
Descrizione

Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
3. body weight 40-100 kg.
Descrizione

Body Weight

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0005910
4. ecog performance status of 0 or 1.
Descrizione

ECOG performance status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224
5. histologically or cytologically confirmed adenocarcinoma of the breast.
Descrizione

Breast adenocarcinoma

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0858252
6. presence of metastatic disease not amenable to surgery, radiation therapy, or chemoradiotherapy with curative intent.
Descrizione

Neoplasm Metastasis | Operative Surgical Procedure Curative Unsuccessful | Therapeutic radiology procedure Curative Unsuccessful | Chemoradiotherapy Curative Unsuccessful

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0027627
UMLS CUI [2,1]
C0543467
UMLS CUI [2,2]
C1276305
UMLS CUI [2,3]
C1272705
UMLS CUI [3,1]
C1522449
UMLS CUI [3,2]
C1276305
UMLS CUI [3,3]
C1272705
UMLS CUI [4,1]
C0436307
UMLS CUI [4,2]
C1276305
UMLS CUI [4,3]
C1272705
7. no active second metastatic malignancy other than breast cancer.
Descrizione

Exclusion Criteria | Neoplasm Metastasis second | Malignant neoplasm of breast Excluded

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2,1]
C0027627
UMLS CUI [2,2]
C0205436
UMLS CUI [3,1]
C0006142
UMLS CUI [3,2]
C2828389
8. no unstable brain or leptomeningeal disease.
Descrizione

Exclusion Criteria | Brain Disease Unstable | Leptomeningeal disease Unstable

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2,1]
C0006111
UMLS CUI [2,2]
C0443343
UMLS CUI [3,1]
C0751297
UMLS CUI [3,2]
C0443343
9. discontinuation of other therapies (except for anastrozole, letrozole, or exemestane) for the treatment of breast cancer and resolution of any acute toxic effects of prior therapies.
Descrizione

Drug therapy discontinued Breast Carcinoma | Exception anastrozole | Exception letrozole | Exception exemestane | Prior Therapy Toxic effect Resolution

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0558681
UMLS CUI [1,2]
C0678222
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0290883
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0246421
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0851344
UMLS CUI [5,1]
C1514463
UMLS CUI [5,2]
C0600688
UMLS CUI [5,3]
C1514893
10. adequate bone marrow, liver, and kidney function.
Descrizione

Bone Marrow function | Liver function | Renal function

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [2]
C0232741
UMLS CUI [3]
C0232804
11. no uncontrolled hypertension, major bleeding, hiv infection or recent acute cardiovascular event.
Descrizione

Exclusion Criteria | Uncontrolled hypertension | Hemorrhage Major | HIV Infection | Cardiovascular event

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2]
C1868885
UMLS CUI [3,1]
C0019080
UMLS CUI [3,2]
C0205164
UMLS CUI [4]
C0019693
UMLS CUI [5]
C1320716
12. if sexually active and not postmenopausal or surgically sterile, willingness to abstain from sexual intercourse or employ an effective barrier method of contraception during the study drug administration and follow-up periods.
Descrizione

Sexually active | Postmenopausal state Absent | Female Sterilization Absent | Sexual Abstinence Willing | Barrier Contraception Usage

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0241028
UMLS CUI [2,1]
C0232970
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C0015787
UMLS CUI [3,2]
C0332197
UMLS CUI [4,1]
C0036899
UMLS CUI [4,2]
C0600109
UMLS CUI [5,1]
C0004764
UMLS CUI [5,2]
C0457083
13. no pregnancy or breast-feeding.
Descrizione

Exclusion Criteria | Pregnancy | Breast Feeding

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2]
C0032961
UMLS CUI [3]
C0006147
14. willingness and ability to comply with scheduled visits, drug administration plan, laboratory tests, other study procedures, and study restrictions.
Descrizione

Protocol Compliance

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0525058
15. willingness to provide informed consent. in addition to the criteria noted above, stage 2 subjects must also have natural or induced suppression of ovarian function to post-menopausal levels and be receiving or be a candidate for hormonal therapy.
Descrizione

Informed Consent | TNM clinical staging Ovarian suppression Level Postmenopausal | Hormone Therapy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2,1]
C3258246
UMLS CUI [2,2]
C0677922
UMLS CUI [2,3]
C0441889
UMLS CUI [2,4]
C0232970
UMLS CUI [3]
C0279025
Ritorna all'inizio della pagina

Similar models

Eligibility Metastatic Breast Cancer NCT00508586

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Gender
Item
1. female sex.
boolean
C0079399 (UMLS CUI [1])
Age
Item
2. age ≥18 years.
boolean
C0001779 (UMLS CUI [1])
Body Weight
Item
3. body weight 40-100 kg.
boolean
C0005910 (UMLS CUI [1])
ECOG performance status
Item
4. ecog performance status of 0 or 1.
boolean
C1520224 (UMLS CUI [1])
Breast adenocarcinoma
Item
5. histologically or cytologically confirmed adenocarcinoma of the breast.
boolean
C0858252 (UMLS CUI [1])
Neoplasm Metastasis | Operative Surgical Procedure Curative Unsuccessful | Therapeutic radiology procedure Curative Unsuccessful | Chemoradiotherapy Curative Unsuccessful
Item
6. presence of metastatic disease not amenable to surgery, radiation therapy, or chemoradiotherapy with curative intent.
boolean
C0027627 (UMLS CUI [1])
C0543467 (UMLS CUI [2,1])
C1276305 (UMLS CUI [2,2])
C1272705 (UMLS CUI [2,3])
C1522449 (UMLS CUI [3,1])
C1276305 (UMLS CUI [3,2])
C1272705 (UMLS CUI [3,3])
C0436307 (UMLS CUI [4,1])
C1276305 (UMLS CUI [4,2])
C1272705 (UMLS CUI [4,3])
Exclusion Criteria | Neoplasm Metastasis second | Malignant neoplasm of breast Excluded
Item
7. no active second metastatic malignancy other than breast cancer.
boolean
C0680251 (UMLS CUI [1])
C0027627 (UMLS CUI [2,1])
C0205436 (UMLS CUI [2,2])
C0006142 (UMLS CUI [3,1])
C2828389 (UMLS CUI [3,2])
Exclusion Criteria | Brain Disease Unstable | Leptomeningeal disease Unstable
Item
8. no unstable brain or leptomeningeal disease.
boolean
C0680251 (UMLS CUI [1])
C0006111 (UMLS CUI [2,1])
C0443343 (UMLS CUI [2,2])
C0751297 (UMLS CUI [3,1])
C0443343 (UMLS CUI [3,2])
Drug therapy discontinued Breast Carcinoma | Exception anastrozole | Exception letrozole | Exception exemestane | Prior Therapy Toxic effect Resolution
Item
9. discontinuation of other therapies (except for anastrozole, letrozole, or exemestane) for the treatment of breast cancer and resolution of any acute toxic effects of prior therapies.
boolean
C0558681 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0290883 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0246421 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0851344 (UMLS CUI [4,2])
C1514463 (UMLS CUI [5,1])
C0600688 (UMLS CUI [5,2])
C1514893 (UMLS CUI [5,3])
Bone Marrow function | Liver function | Renal function
Item
10. adequate bone marrow, liver, and kidney function.
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
Exclusion Criteria | Uncontrolled hypertension | Hemorrhage Major | HIV Infection | Cardiovascular event
Item
11. no uncontrolled hypertension, major bleeding, hiv infection or recent acute cardiovascular event.
boolean
C0680251 (UMLS CUI [1])
C1868885 (UMLS CUI [2])
C0019080 (UMLS CUI [3,1])
C0205164 (UMLS CUI [3,2])
C0019693 (UMLS CUI [4])
C1320716 (UMLS CUI [5])
Sexually active | Postmenopausal state Absent | Female Sterilization Absent | Sexual Abstinence Willing | Barrier Contraception Usage
Item
12. if sexually active and not postmenopausal or surgically sterile, willingness to abstain from sexual intercourse or employ an effective barrier method of contraception during the study drug administration and follow-up periods.
boolean
C0241028 (UMLS CUI [1])
C0232970 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0015787 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0036899 (UMLS CUI [4,1])
C0600109 (UMLS CUI [4,2])
C0004764 (UMLS CUI [5,1])
C0457083 (UMLS CUI [5,2])
Exclusion Criteria | Pregnancy | Breast Feeding
Item
13. no pregnancy or breast-feeding.
boolean
C0680251 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
Protocol Compliance
Item
14. willingness and ability to comply with scheduled visits, drug administration plan, laboratory tests, other study procedures, and study restrictions.
boolean
C0525058 (UMLS CUI [1])
Informed Consent | TNM clinical staging Ovarian suppression Level Postmenopausal | Hormone Therapy
Item
15. willingness to provide informed consent. in addition to the criteria noted above, stage 2 subjects must also have natural or induced suppression of ovarian function to post-menopausal levels and be receiving or be a candidate for hormonal therapy.
boolean
C0021430 (UMLS CUI [1])
C3258246 (UMLS CUI [2,1])
C0677922 (UMLS CUI [2,2])
C0441889 (UMLS CUI [2,3])
C0232970 (UMLS CUI [2,4])
C0279025 (UMLS CUI [3])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial